BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20350230)

  • 1. Monotypic epithelioid angiomyolipoma of the liver with TFE3 expression.
    Wen MC; Jan YJ; Li MC; Wang J; Lin A
    Pathology; 2010 Apr; 42(3):300-2. PubMed ID: 20350230
    [No Abstract]   [Full Text] [Related]  

  • 2. Premelanosome-negative inflammatory angiomyolipoma of liver with expression of cathepsin K and TFE3.
    Sun K; Zhao M; Yao H; Wang L; Wei J
    Int J Clin Exp Pathol; 2014; 7(11):8170-5. PubMed ID: 25550868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid diffuse large B cell lymphoma (DLBCL) following thyroid medullary cancer: long-term complete remission with R-CHOP therapy.
    Dai CW; Zhang GS; Pei MF; Shen JK
    Ann Hematol; 2009 Jul; 88(7):701-2. PubMed ID: 19015853
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case report of composite lymphoma].
    Wu J; Wang ZC; Chen XD
    Ai Zheng; 2007 Apr; 26(4):447. PubMed ID: 17430672
    [No Abstract]   [Full Text] [Related]  

  • 5. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
    Lee KW; Kim DY; Yun T; Kim DW; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
    Cancer; 2003 Dec; 98(12):2651-6. PubMed ID: 14669285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary mediastinal large B-cell lymphoma.
    Ergul SM; Lal A; Afri L; Frei-Lahr D
    South Med J; 2002 Sep; 95(9):1005-7. PubMed ID: 12356098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1-positive diffuse large B-cell lymphoma.
    Rodriguez-Justo M; Huang Y; Ye H; Liu H; Chuang SS; Munson P; Prada-Puentes C; Kim I; Du MQ; Bacon CM
    Histopathology; 2008 Jun; 52(7):900-3. PubMed ID: 18494615
    [No Abstract]   [Full Text] [Related]  

  • 8. Conjunctival lymphoma in a child.
    Waisbourd M; Leibovitch I; Sayar D; Elhasid R
    Cornea; 2011 May; 30(5):598-9. PubMed ID: 21107252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin's lymphoma (diffuse large B cell lymphoma).
    Copson E
    Clin Evid; 2006 Jun; (15):30-44. PubMed ID: 16973004
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary testicular lymphoma.
    Lobo FD; Bansal R; Naik R; Pai MR; Dinesh D
    J Indian Med Assoc; 1998 Jun; 96(6):193-4. PubMed ID: 9834575
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular outcome prediction in diffuse large-B-cell lymphoma.
    Alizadeh AA; Gentles AJ; Lossos IS; Levy R
    N Engl J Med; 2009 Jun; 360(26):2794-5. PubMed ID: 19553658
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary cutaneous diffuse large B cell lymphoma, leg type.
    Dongre A; Kar S; Gondse S; Gangane N; Mehra BK
    Indian J Dermatol Venereol Leprol; 2011; 77(2):212-4. PubMed ID: 21393962
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
    Chang PM; Chen PM; Hsieh SL; Tzeng CH; Liu JH; Chiou TJ; Wang WS; Yen CC; Gau JP; Yang MH
    Int J Oncol; 2008 Sep; 33(3):549-54. PubMed ID: 18695885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.
    Feugier P; Van Hoof A; Sebban C; Solal-Celigny P; Bouabdallah R; Fermé C; Christian B; Lepage E; Tilly H; Morschhauser F; Gaulard P; Salles G; Bosly A; Gisselbrecht C; Reyes F; Coiffier B
    J Clin Oncol; 2005 Jun; 23(18):4117-26. PubMed ID: 15867204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary large B-cell lymphoma of the bone marrow.
    Hishizawa M; Okamoto K; Chonabayashi K; Kaneko H; Watanabe M; Tsudo M
    Br J Haematol; 2007 Feb; 136(3):351. PubMed ID: 17233843
    [No Abstract]   [Full Text] [Related]  

  • 16. Orbital plasmablastic lymphoma--comparison of a newly reported entity with diffuse large B-cell lymphoma of the orbit.
    Morley AM; Verity DH; Meligonis G; Rose GE
    Orbit; 2009; 28(6):425-9. PubMed ID: 19929677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Destructive midline palatal lesion.
    Loudon JA; Marsh WL; Allen CM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Feb; 89(2):134-6. PubMed ID: 10673645
    [No Abstract]   [Full Text] [Related]  

  • 18. Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.
    Hosoi M; Yamamoto G; Imai Y; Kurokawa M
    Ann Hematol; 2010 Feb; 89(2):207-8. PubMed ID: 19582454
    [No Abstract]   [Full Text] [Related]  

  • 19. A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
    Micallef IN; Kahl BS; Maurer MJ; Dogan A; Ansell SM; Colgan JP; Geyer S; Inwards DJ; White WL; Habermann TM
    Cancer; 2006 Dec; 107(12):2826-32. PubMed ID: 17099879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients.
    Guyot A; Ortonne N; Valeyrie-Allanore L; Bagot M
    Arch Dermatol; 2010 Jan; 146(1):89-91. PubMed ID: 20083704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.